0-9
A B C D E F G H I J K L M N O
P Q R S T U V W X Y Z
  • No FAQs found
  • No FAQs found
  • No FAQs found
  • No FAQs found
  • No FAQs found
  • No FAQs found
  • No FAQs found

Sequential Integrated Screen, Part 1

Test code(s) 16131, 16974 (NY)

This is an outdated version of this FAQ. It was effective 05/15/2013 to 03/17/2015.

The current version is available here.

Question 1. Why does the Down syndrome and trisomy 18 result on the Sequential Integrated Screen, Part 1 test indicate In Process?

An In Process result means the Down syndrome and trisomy 18 risks did not exceed the Part 1 cutoffs. To complete the test and obtain a final result, please submit a second trimester sample (test code 16133 [16975 for NY]) within the date range provided on the report.

Question 2. My patient’s result was High risk for Down syndrome on the Sequential Integrated Screen Part 1 test. What should I do next?

A High risk for Down syndrome result means there is an increased risk for the fetus to be affected with Down syndrome or other chromosome abnormality. The demographic information provided at the time of testing is used in calculating the patient’s Down syndrome risk. Please check the demographic information to ensure accuracy of calculated results.

Guidelines recommend counseling women with a positive screening test. Such counseling may include a discussion of the significance of the screening results and diagnostic testing options (eg, chorionic villus or amniocentesis testing). Guidelines do not recommend repeating Down syndrome positive screening tests.

Question 3. My patient’s result was High risk for trisomy 18 on the Sequential Integrated Screen Part 1 test. What should I do next?

A High risk for trisomy 18 result means there is an increased risk for the fetus to be affected with trisomy 18 or other chromosome abnormality. The demographic information provided at the time of testing is used in calculating the patient’s trisomy 18 risk. Please check the demographic information to ensure accuracy of calculated results.

Guidelines recommend counseling women with a positive screening test. Such counseling may include a discussion of the significance of the screening results and diagnostic testing options (eg, chorionic villus or amniocentesis testing). Guidelines do not recommend recalculating or repeating trisomy 18 positive screening tests.

Question 4. The report indicates a different gestational age than what I determined. How is the gestational age calculated?

The gestational age is calculated from the crown rump length (CRL) provided, using criteria from the Fetal Medicine Foundation. If the CRL is not provided, the gestational age is derived from the expected date of delivery (EDD) and the collection date provided and is an exact calculation by calendar days. Gestational wheels may be inaccurate by several days or more.

Note that the gestational age is reported in decimal weeks. For example, 11 weeks 4 days is reported as 11.6 weeks.

Question 5. When is it appropriate to change the gestational age or estimated date of delivery (EDD) on a maternal serum screen result report?

It is appropriate to change the gestational age or EDD when the data used for screening are substantially above or below that determined by ultrasound.

The earliest EDD calculated by ultrasound should be used for dating purposes. An ultrasound derived EDD is most accurate when determined in the first trimester. Accuracy decreases with advancing gestational age. For example, accuracy of an ultrasound EDD is ±7 days in the first trimester and ±10 days in the second trimester.

If a first trimester ultrasound EDD is available and the gestational age used for screening is within the EDD ±7 days, the gestational age should not be changed for screening purposes. If the gestational age used for screening is outside the ultrasound EDD range, it may be appropriate to change the gestational age used for screening.

If you want to change the EDD/gestational age used for a specific patient’s screening test, please contact your local Quest Diagnostics laboratory or call 866-GENE-INFO. If the revised gestational age is between 10.0 to 13.9 weeks’ gestation, we can calculate and report new risks. If the revised gestational age is <10.0 weeks, we cannot calculate new risks. Consider submitting a second specimen for screening, collected when the patient is between 10.0 to 13.9 weeks’ gestation. If the revised gestational age is >13.9 weeks gestation, we cannot calculate new risks and a more accurate risk assessment cannot be provided.

Question 6. My patient has a family history of NTD, Down syndrome, or trisomy 18. What impact does this have on these results?

Please call 866-GENE-INFO to discuss this case with a genetic counselor. Documentation of the abnormality in the family may enable a more specific risk assessment or indicate whether additional studies should be performed.

Question 7. What is a Down syndrome pseudo-risk in a twin gestation? Why don't we give twin-specific risks?

Prenatal screening in twin pregnancies is complex. The serum markers can be measured in a patient with a twin gestation and then divided by corresponding medians for unaffected singleton pregnancies to calculate multiple of medians (MoMs). These MoMs are then adjusted for twins in order to provide a pseudo-risk for Down syndrome. This calculation accounts for the presence of two fetuses and also takes into account the chorionicity of the pregnancy and the nuchal translucency measurement of each specific fetus. The result is a pregnancy-specific pseudo-risk, rather than a fetus-specific risk.

Question 8. In a twin gestation, why is there no risk assessment reported for trisomy 18?

Prenatal screening in twin pregnancies is complex. A trisomy 18 risk assessment is not calculated for twin gestations due to insufficient screening marker data from affected twin pregnancies.

 

References

  1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosome abnormalities. Obstet Gynecol. 2007;109:217-227.
This FAQ is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

Document FAQS.89 Revision: 0